Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023.
Fleming-Dutra KE, Ciesla AA, Roper LE, Smith ZR, Miller JD, Accorsi EK, Verani JR, Shang N, Derado G, Wiegand RE, Pilishvili T, Britton A, Link-Gelles R. Fleming-Dutra KE, et al. MMWR Morb Mortal Wkly Rep. 2023 Feb 17;72(7):177-182. doi: 10.15585/mmwr.mm7207a3. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36795625 Free PMC article.
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.
Regan JJ, Moulia DL, Link-Gelles R, Godfrey M, Mak J, Najdowski M, Rosenblum HG, Shah MM, Twentyman E, Meyer S, Peacock G, Thornburg N, Havers FP, Saydah S, Brooks O, Talbot HK, Lee GM, Bell BP, Mahon BE, Daley MF, Fleming-Dutra KE, Wallace M. Regan JJ, et al. MMWR Morb Mortal Wkly Rep. 2023 Oct 20;72(42):1140-1146. doi: 10.15585/mmwr.mm7242e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37856366 Free PMC article.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
Tenforde MW, Weber ZA, Natarajan K, Klein NP, Kharbanda AB, Stenehjem E, Embi PJ, Reese SE, Naleway AL, Grannis SJ, DeSilva MB, Ong TC, Gaglani M, Han J, Dickerson M, Fireman B, Dascomb K, Irving SA, Vazquez-Benitez G, Rao S, Konatham D, Patel P, Schrader KE, Lewis N, Grisel N, McEvoy C, Murthy K, Griggs EP, Rowley EAK, Zerbo O, Arndorfer J, Dunne MM, Goddard K, Ray C, Zhuang Y, Timbol J, Najdowski M, Yang DH, Hansen J, Ball SW, Link-Gelles R. Tenforde MW, et al. MMWR Morb Mortal Wkly Rep. 2022 Dec 30;71(5152):1616-1624. doi: 10.15585/mmwr.mm715152e1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36580430 Free PMC article.
Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months - 20 U.S. Jurisdictions, September 18, 2022-April 1, 2023.
Johnson AG, Linde L, Payne AB, Ali AR, Aden V, Armstrong B, Armstrong B, Auche S, Bayoumi NS, Bennett S, Boulton R, Chang C, Collingwood A, Cueto K, Davidson SL, Du Y, Fleischauer A, Force V, Frank D, Hamilton R, Harame K, Harrington P, Hicks L, Hodis JD, Hoskins M, Jones A, Kanishka F, Kaur R, Kirkendall S, Khan SI, Klioueva A, Link-Gelles R, Lyons S, Mansfield J, Markelz A, Masarik J 3rd, Mendoza E, Morris K, Omoike E, Paritala S, Patel K, Pike M, Pompa XP, Praetorius K, Rammouni N, Razzaghi H, Riggs A, Shi M, Sigalo N, Stanislawski E, Tilakaratne BP, Turner KA, Wiedeman C, Silk BJ, Scobie HM. Johnson AG, et al. MMWR Morb Mortal Wkly Rep. 2023 Jun 16;72(24):667-669. doi: 10.15585/mmwr.mm7224a6. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37319029 Free PMC article. No abstract available.
A framework for monitoring RSV prevention product effectiveness in the United States.
Roper LE, Link-Gelles R, Surie D, DeCuir J, Zambrano LD, Prill MM, Havers FP, Jones JM, Melgar M, Hall AJ, Whitehead RD Jr, McMorrow ML, Ioannou GN, Hernandez-Romieu AC, Britton A, Novosad S, Martin A, Feldstein LR, Bajema KL, Kirking H, Moline H, Campbell AP, Aslan M, Hatfield K, Dawood F, Slayton R, Reddy S, Gomes D, Fleming-Dutra KE, Payne AB. Roper LE, et al. Among authors: link gelles r. Vaccine. 2025 Jan 25;45:126633. doi: 10.1016/j.vaccine.2024.126633. Epub 2025 Jan 3. Vaccine. 2025. PMID: 39755055
Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States.
Tenforde MW, Reeves EL, Weber ZA, Tartof SY, Klein NP, Dascomb K, DeSilva MB, Yang DH, Grannis SJ, Irving SA, Ong TC, Link-Gelles R, Salas SB, Sy LS, Lewin B, Contreras R, Zerbo O, Fireman B, Hansen J, Timbol J, Sheffield T, Bride D, Arndorfer J, VanOtterloo J, McEvoy CE, Akinsete OO, Essien IJ, Dixon BE, Rogerson C, Fadel WF, Duszynski T, Naleway AL, Barron MA, Rao S, Mayer D, Chavez C, Ball SW, Payne AB, Ray C, Dickerson M, Neelam V, Adams K, Flannery B, DeCuir J, Garg S. Tenforde MW, et al. Among authors: link gelles r. Clin Infect Dis. 2024 Dec 4:ciae597. doi: 10.1093/cid/ciae597. Online ahead of print. Clin Infect Dis. 2024. PMID: 39656838
Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children - Yukon-Kuskokwim Delta Region, Alaska, October 2023-June 2024.
Lefferts B, Bressler S, Keck JW, Desnoyers C, Hodges E, January G, Morris K, Herrmann L, Singleton R, Aho S, Rogers J, Newell K, Ohlsen E, Link-Gelles R, Dawood FS, Bruden D, Fischer M, Klejka J, Scobie HM. Lefferts B, et al. Among authors: link gelles r. MMWR Morb Mortal Wkly Rep. 2024 Nov 14;73(45):1015-1021. doi: 10.15585/mmwr.mm7345a1. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39541241 Free PMC article.
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection-Increasing Community Access to Testing Program, United States, January-September 2023.
Ciesla AA, Mak J, Roper LE, Fleming-Dutra KE, Smith ZR, Wiegand RE, Britton A, Miller J, Link-Gelles R. Ciesla AA, et al. Among authors: link gelles r. Influenza Other Respir Viruses. 2024 Nov;18(11):e70038. doi: 10.1111/irv.70038. Influenza Other Respir Viruses. 2024. PMID: 39522959 Free PMC article.
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
Payne AB, Watts JA, Mitchell PK, Dascomb K, Irving SA, Klein NP, Grannis SJ, Ong TC, Ball SW, DeSilva MB, Natarajan K, Sheffield T, Bride D, Arndorfer J, Naleway AL, Koppolu P, Fireman B, Zerbo O, Timbol J, Goddard K, Dixon BE, Fadel WF, Rogerson C, Allen KS, Rao S, Mayer D, Barron M, Reese SE, Rowley EAK, Najdowski M, Ciesla AA, Mak J, Reeves EL, Akinsete OO, McEvoy CE, Essien IJ, Tenforde MW, Fleming-Dutra KE, Link-Gelles R. Payne AB, et al. Among authors: link gelles r. Lancet. 2024 Oct 19;404(10462):1547-1559. doi: 10.1016/S0140-6736(24)01738-0. Lancet. 2024. PMID: 39426837
122 results